UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Scale-down Technologies for Perfusion Culture for Rapid Biopharmaceutical Process Development

Tregidgo, Molly Beth; (2022) Scale-down Technologies for Perfusion Culture for Rapid Biopharmaceutical Process Development. Doctoral thesis (Eng.D), UCL (University College London). Green open access

[thumbnail of Tregidgo_10145185_Thesis.pdf]
Preview
Text
Tregidgo_10145185_Thesis.pdf

Download (9MB) | Preview

Abstract

Perfusion culture is becoming an increasingly popular choice for the production of therapeutic proteins, however few scale-down devices capable of small scale and/or high throughput optimisation of high cell density perfusion cultures have been published. To address this technology gap, this thesis describes the development, implementation, and engineering characterisation of two scale-down technologies; (i) a quasi-perfusion method at mL-scale in microwell plates (MWPs) and (ii) a purposely designed novel bioreactor (BR) at 250mL scale. Quasi-perfusion in MWP was developed at mL-scale and is capable of achieving many of the specific characteristics of perfusion culture, namely elevated cell density, cell retention and good productivity. The quasi-perfusion methodology was implemented to screen a range of process conditions, exchanging at a constant vessel volume per day (VVD) between 0.5-1.8, or at constant cell specific perfusion rate (CSPR) with a range of media, with cell retention achieved via sedimentation or centrifugation. Viable cell densities (VCDs) of 42 × 10^{6} cells mL-1and volumetric productivities up to 2 fold greater than fed-batch were achieved. Design and engineering characterisation of the novel 250mL BR ensured favourable hydrodynamics, with a dual impeller system selected to maximise mass transfer. Cell retention was achieved via a tangential flow filter (TFF) at perfusion rates between 0.5- 1.8 VVD, maintaining maximum VCDs of 92 × 10^{6} cells mL-1 at >95% viability. Good scalability was demonstrated for a range of performance metrics, including µmax, qAb and biomass production, between each system when compared to a bench scale 5L BR, while scaling was based on constant volumetric power input. The combined use of quasi-perfusion methodologies, shown to be sensitive to changes in perfusion rate and media composition, for high throughput screening studies, followed by the 250mL BR for in-depth study of a small range of conditions, is shown to be a powerful tool for the development and optimisation of perfusion processes.

Type: Thesis (Doctoral)
Qualification: Eng.D
Title: Scale-down Technologies for Perfusion Culture for Rapid Biopharmaceutical Process Development
Open access status: An open access version is available from UCL Discovery
Language: English
Additional information: Copyright © The Author 2022. Original content in this thesis is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request.
UCL classification: UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10145185
Downloads since deposit
606Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item